SIGN UP
LOG IN
L
LXRX
Lexicon Pharmaceuticals Inc
0.67
0.03+5.38%After Hours: 0.6700 -0.00 -0.27%19:50 04/23 EDT
OPEN/PREV CLOSE0.6380/0.6375
TODAY RANGE0.6279-0.6900
VOL7.70M
MARKET CAP242.85M
52 WEEK RANGE0.2836-2.450
AVG VOL (3M)15.47M
% TURNOVER2.13%
TURNOVER--
P/E (TTM)-1.0728
% RANGE9.74%
EPS(TTM)-0.6262
P/E(FORWARD)-1.8157
P/B1.664
BVPS0.4037
DIVIDEND--
P/S7.81
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP239.85M
SHARES OUTSTANDING361.49M
NEXT EARNINGS04/30-05/05
FREE FLOAT357.02M
LOT SIZE1
EX-DIV DATE05/21/2015
News
Press Releases
Financial Reports
Profile
TipRanks·04/10 12:45
Largest borrow rate increases among liquid names
TipRanks·04/08 12:45
Largest borrow rate increases among liquid names
TipRanks·04/04 12:52
Largest borrow rate increases among liquid names
NASDAQ·04/02 14:18
LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?
TipRanks·04/02 12:45
Largest borrow rate increases among liquid names
TipRanks·03/31 16:40
Biotech Alert: Searches spiking for these stocks today
Benzinga·03/31 09:29
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
Benzinga·03/31 05:25
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
Seeking Alpha·03/30 13:05
Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
Seeking Alpha·03/28 22:10
Lexicon's Drug Discovery Engine Validated By Novo's $1 Billion Obesity Drug Deal (Upgrade)
Benzinga·03/28 18:00
What 6 Analyst Ratings Have To Say About Lexicon Pharmaceuticals
Dow Jones·03/28 17:37
Lexicon Pharma Price Target Maintained With a $4.00/Share by HC Wainwright & Co.
Benzinga·03/28 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.